-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Inozyme Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2024.
- Inozyme Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $1.86M, a 9.82% increase year-over-year.
- Inozyme Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $8.11M, a 22.2% increase year-over-year.
- Inozyme Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $7.95M, a 12.9% increase from 2023.
- Inozyme Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.04M, a 8.61% decline from 2022.
- Inozyme Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.7M, a 6.94% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)